Intestinal tuberculosis presenting as fever of unknown origin in a heart transplant patient.
Patients undergoing transplantation have an increased risk of developing infections such as tuberculosis, Pneumocystis carinii pneumonia, Candida infections or cytomegalovirus infections because of their immunosuppressive therapy with cyclosporin A, azathioprine and steroids. Mycobacterial infection is well recognized as a complication in the immunocompromised host but diagnosis and therapy are very difficult.
Zedtwitz-Liebenstein
K
K
Universitätsklinik für Innere Medizin I, Abt. für Infektionen und Chemotherapie, Allgemeines Krankenhaus, Universitätsklinik für Innere Medizin, Wien, Austria.
Podesser
B
B
Peck-Radosavljevic
M
M
Graninger
W
W
D000995:Antitubercular Agents / Q000008:administration & dosage; D003108:Colonic Diseases / Q000382:microbiology*; D005335:Fever of Unknown Origin / Q000209:etiology*; D005500:Follow-Up Studies; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification*; D016896:Treatment Outcome; D014385:Tuberculosis, Gastrointestinal / Q000150:complications* / Q000175:diagnosis*
D000995:Antitubercular Agents